PO38 | Rates of hemorrhagic events and hemodialysis circuit thrombosis in patients with end-stage renal disease on hemodialytic treatment receiving a factor-XI inhibitor: a systematic review and meta-analysis
Background and Aims: In patients undergoing hemodialysis, anticoagulants are commonly used to reduce thromboembolic events and circuit thrombosis. However, patients affected by end-stage renal disease (ESRD) are considered at higher risk of hemorrhagic events. Inhibiting coagulation Factor XI (FXI)...
Saved in:
| Format: | Article |
|---|---|
| Language: | English |
| Published: |
PAGEPress Publications
2025-08-01
|
| Series: | Bleeding, Thrombosis and Vascular Biology |
| Subjects: | |
| Online Access: | https://www.btvb.org/btvb/article/view/301 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|